Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Evaluation of the Efficacy and Safety of Zortress (Everolimus)/Myfortic (Enteric Coated Mycophenolate Sodium) Conversion in High MELD Liver Transplantation

NCT01807767 is registered in ClinicalTrials.gov with Medical College of Wisconsin as lead sponsor.

NCT NCT01807767
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01807767 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Evaluation of the Efficacy and Safety of Zortress (Everolimus)/Myfortic (Enteric Coated Mycophenolate Sodium) Conversion in High MELD Liver Transplantation
Lead sponsor
Medical College of Wisconsin
Phase
Not applicable
Overall status
Withdrawn
Start date
March 31, 2013
Completion date
August 31, 2015
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

high model for end-stage liver disease (meld) score